does semaglutide regulate period Ozempic and Menstrual Cycles: What You Need to Know Before Starting Understanding the Impact of Weight

Van Raalte Frontiers in Endocrinology doi 10.3389/fendo.2021.645563 435,236 views 325 citations Case Report Published on 29 Aug 2023 Case Report: Semaglutide-associated depression: a report of two cases in Mood Disorders Jia-Rui Li Jinya Cao Jing Wei Wenqi Geng Frontiers in Psychiatry doi 10.3389/fpsyt.2023.1238353 42,947 views 51 citations Systematic Review Published on 05 Jul 2024 Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis in Clinical and Translational Cardiovascular Medicine Walter Masson Martn Lobo Juan Patricio Nogueira Alfredo Matias Rodriguez-Granillo Leandro Ezequiel Barbagelata Daniel Siniawski Frontiers in Cardiovascular Medicine doi 10.3389/fcvm.2024.1379189 19,750 views 49 citations Case Report Published on 21 Jan 2025 Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review in Obesity Andrijana Koceva Katarina Mleku Kozamernik Andrej Jane Rok Herman Simona Ferjan Mojca Jensterle Frontiers in Endocrinology doi 10.3389/fendo.2024.1528457 14,419 views 6 citations Original Research Published on 07 Oct 2024 SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice in Renal Pharmacology Nerea Martos-Guillami Ander Vergara Carmen Llorens-Cebri Aku Enam Motto Irene Martnez-Daz Francisco Gonalves Maria Magdalena Garcias-Ramis Estibaliz Allo-Urzainqui Alonso Narvez Sheila Bermejo Frontiers in Pharmacology doi 10.3389/fphar.2024.1415879 7,350 views 9 citations Systematic Review Published on 06 Oct 2021 Efficacy and Safety of Subcutaneous and Oral Semaglutide Administration in Patients With Type 2 Diabetes: A Meta-Analysis in Drugs Outcomes Research and Policies Ping Zhong Hai Zeng Miaochun Huang Guoxin He Zhixia Chen Frontiers in Pharmacology doi 10.3389/fphar.2021.695182 15,518 views 21 citations Original Research Published on 14 Aug 2024 The effectiveness of 0.5 mg and 1mg of semaglutide in patients with type two diabetes and predictors of response: a retrospective cohort study in Clinical Diabetes Sara Alenzi Abdullah Alzahrani Afnan Aljaloud Kamayel Alanazi Sumaiah J

Through personal reflection, it explores the individual occupational impacts of using such medications and the assumptions around obesity - drawing on links from experience working in the field of substance use

So the main limitation is not evidence of harm, but rather a lack of sufficient long-term, high-quality data to draw firm conclusions

The rest of this article is preserved as historical context about how the waitlist developed